Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
non-small-cell lung cancer (NSCLC)
.
Show all posts
Showing posts with label
non-small-cell lung cancer (NSCLC)
.
Show all posts
Thursday, March 24, 2016
Afatinib a better choice for EGFR-mutated lung cancer in first-line treatment
›
In continuation of my update on Afatinib Patients with EGFR-activating mutations in advanced lung cancer seem to benefit more fr...
›
Home
View web version
